Exhaled nitric oxide levels in systemic sclerosis with and without pulmonary involvement

Chest

Volumn 132, Issue 2, 2007, Pages 575-580

  Malerba, Mario ^a   Radaeli, Alessandro ^a   Ragnoli, Beatrice ^a   Airo', Paolo ^a   Corradi, Massimo ^b   Ponticiello, Antonio ^c   Zambruni, Alberto ^a   Grassi, Vittorio ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Exhaled nitric oxide; Interstitial lung disease; Pulmonary hypertension; Systemic sclerosis

Indexed keywords

NITRIC OXIDE;

ADULT; ARTICLE; CAUSE OF DEATH; CHEMOMETRIC ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG DISEASE; LUNG FUNCTION TEST; MALE; MEASUREMENT; PREDICTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; STATISTICAL SIGNIFICANCE; SYSTEMIC SCLEROSIS; SYSTOLIC BLOOD PRESSURE;

EID: 34548022633     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-2929     Document Type: Article

References (30)

1. Black CM, du Bois RM. Pulmonary organ involvement. In: Clements P, Furst DE, eds. Systemic sclerosis. Baltimore, MD: Williams and Wilkins, 1996; 299-333
2. Ungerer RG, Tashkin DP, Furst D, et al. Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med 1983; 75:65-74
3. Prescott RJ, Freemont AJ, Jones CJ, et al. Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 1992; 166:255-263
4. Harrison NK, Myers AR, Corrin B, et al. Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis 1991; 144(3 pt 1):706-713
5. Stamler JS, Loh E, Roddy MA, et al. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 1994; 89:2035-2040
6. al-Ali MK, Howarth PH. Nitric oxide and the respiratory system in health and disease. Respir Med 1998; 92:701-715
7. Barnes PJ, Belvisi MG. Nitric oxide and lung disease. Thorax 1993; 48:1034-1043
8. Eiserich JP, Patel RP, O'Donnell VB. Pathophysiology of nitric oxide and related species: free radical reactions and modification of biomolecules. Mol Aspects Med 1998; 19:221-357
9. Kharitonov SA, Cailes JB, Black CM, et al. Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension. Thorax 1997; 52:1051-1055
10. Fajac I, Kahan A, Menkes CJ, et al. Increased nitric oxide in exhaled air in patients with systemic sclerosis. Clin Exp Rheumatol 1998; 16:547-552
11. Rolla G, Colagrande P, Scappaticci E, et al. Exhaled nitric oxide in systemic sclerosis: relationships with lung involvement and pulmonary hypertension. J Rheumatol 2000; 27:1693-1698
12. Moodley YP, Lalloo UG. Exhaled nitric oxide is elevated in patients with progressive systemic sclerosis without interstitial lung disease. Chest 2001; 119:1449-1454
13. Girgis RE, Gugnani MK, Abrams J, et al. Partitioning of alveolar and conducting airway nitric oxide in scleroderma lung disease. Am J Respir Crit Care Med 2002; 165:1587-1591
14. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23:581-590
15. MacGregor AJ, Canavan R, Knight C, et al. Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival. Rheumatology 2001; 40:453-459
16. Rubin LJ. Executive summary: diagnosis and management of pulmonary arterial hypertension; ACCP evidence-based clinical practice guidelines. Chest 2004; 126:4S-6S
17. Clausen JL, Coates AL, Quanjer PH. Measurement of lung volumes in humans: review and recommendations from an ATS/ERS workshop. Eur Respir J 1997; 10:1205-1206
18. American Thoracic Society. Single breath carbon monoxide diffusion capacity (transfer factor): recommendation for a standard technique, 1995 update. Am J Respir Crit Care Med 1995; 152:2185-2198
19. ATS/ERS. Recommendations for standardized procedures for online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171:912-930
20. Corradi M, Pelizzoni A, Majori M, et al. Influence of atmospheric nitric oxide concentration on the measurement of nitric oxide in exhaled air. Thorax 1998; 53:673-676
21. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002; 165:277-304
22. Dupont WD, Plummer WD. PS power and sample size program available for free on the Internet. Control Clin Trials 1997; 18:274
23. Olivieri M, Talamini G, Corradi M, et al. Reference values for exhaled nitric oxide (REVENO) study. Respir Res 2006; 7:94-99
24. Harrison NK, Myers AR, Corrin B, et al. Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis 1991; 144(3 pt 1):706-713
25. Saleh D, Barnes PJ, Giaid A. Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997; 155:1763-1769
26. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995; 333:214-221
27. Dinh-Xuan AT, Higenbottam TW, Clelland CA, et al. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med 1991; 324:1539-1547
28. Clini E, Cremona G, Campana M, et al. Production of endogenous nitric oxide in chronic obstructive pulmonary disease and patients with cor pulmonale: correlates with echo-Doppler assessment. Am J Respir Crit Care Med 2000; 162(2 pt 1):446-450
29. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001; 163:1693-1722
30. Desai SR, Veeraraghavan S, Hansell DM, et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 2004; 232:560-567